Merci !!!
Nos travailleurs vous remercient à leur tour !
Coronavirus COVID-19 – Appeal for donations
The Friends of the Bordet Institute” has opened a “COVID-19” donations account - BE78 0018 3100 0086
Covid19 : Call for volunteers
The public hospitals in Brussels need you once again!
Covid-19 – Collecte de dons pour les héros d’iris
Aidez-nous à donner des super pouvoirs à nos héros. Faites un don !
Bordet News 130 (March 2020)
FLAH INFO CORONAVIRUS
National health plan for cancer patients!
A national health plan for cancer patients to avoid a wave of collateral victims!
Le CHU Bruxelles, acteur hospitalier d’envergure dans l’économie bruxelloise
1 milliard de retombées économiques et près de 7.800 emplois générés à Bruxelles en 2016.
Whether or not to participate in a clinical trial
The Jules Bordet Institute is developing an innovative digital tool to support patients in their decision-making. To develop, with the assistance of patients, a digital tool that enables patients to decide in full knowledge of the fact
Reduction of the risk of breast cancer recurrence
The administration of an anti-inflammatory drug during the ablation of the primary tumour reduces the risk of breast cancer recurrence in overweight or obese patients
Tips to avoid melanoma now that spring has sprung
We're full of the joys of spring. But be careful what it might bring! Here are a few tips to avoid melanoma now that spring has sprung.
Lambertine-Lacroix Prize - Cancerology 2018: Ch Desmedt
Prize awarded to the researcher Christine Desmedt of the Jules Bordet Institute, ULB.
The new generation of researchers doubly rewarded
Double Merit Award of the Conquer Cancer Foundation of ASCO for 2 young researchers at the Institut Jules Bordet
Oncodistinct, a multidisciplinary clinical research network
Oncodistinct, a multidisciplinary clinical research network that meets patients' needs
101 Tables pour la vie
05/06/2018 : Gastronomic evening benefiting the research laboratories of the new Institut Bordet
Tombola 2018 of the Friends of the Institut Bordet
DRAW : 04/07/2018 - 1st prize: a stay for 2 people in VIENNA
Personalization of treatment of HER2+ breast cancer
(Dr Ignatiadis) A patient’s immune response makes it possible to personalize treatment of HER2 positive breast cancer.
Stop smoking is possible!
On the occasion of World No Tobacco Day the Jules Bordet Institute separates the myths from the facts
“Missing Type” Red Cross Campaign
The Jules _ordet Institute is playing the game! From June 11, 2018 till June 18, 2018, the Red Cross is launching the “Missing Type” movement.
Jules Bordet Institute accredited by the OECI
The Jules Bordet Institute is officially recognised by the OECI as a "Comprehensive Cancer Centre".